ArticleUltrasonics sonochemistry2025
A flexible cystoscopy device prototype for mechanical tissue ablation based on micro-scale hydrodynamic cavitation: Ex vivo and in vivo studies.
Article in Ultrasonics sonochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Fundamentals of acoustic and hydrodynamic cavitation.Ultrasonics sonochemistry · 2025Article
- The application of hydrodynamic cavitation technology and the synergistic effect of hybrid advanced oxidation processes: a review.Water science and technology : a journal of the International Association on Water Pollution Research · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Minimally invasive methods were sought for faster recovery from benign prostatic hyperplasia (BPH) and lower urinary tract (LUTS) symptoms. For this, the search for effective, low-side-effect methods for tissue ablation, particularly for managing BPH and certain bladder pathologies, has been continued to advance. In this regard, the energy released during the formation of hydrodynamic cavitation bubbles offers an alternative treatment method. In this study, we present the feasibility of the use of hydrodynamic cavitation with a flexible cystoscopy device prototype designed for the treatment of LUTS-related diseases. The developed flexible cystoscopy device prototype allows easy access to the urinary bladder through urethra with minimal pain, demonstrating its suitability as a minimally invasive approach. Precisely targeted cavitation exposure prevents prostatic capsule and bladder perforation. Moreover, an automatic actuating mechanism supports steering for real-time visual feedback. The developed device prototype was first tested on an ex vivo human bladder and then on an in vivo porcine bladder. Histopathological analyses were performed after both species were tested. For both analyses, significant tissue ablation at the targets was observed upon exposure to cavitating flows. Finally, the temperature profile on the device was obtained using a thermal camera. Accordingly, it was observed that the temperature increase during the procedure was not significant. The developed device prototype can thus realize mechanical ablation-based therapy, avoids unintended heat deposition which might appear in laser ablation and leads to fewer side effects such as uncontrolled tissue damage and low target area effectiveness that might occur in minimally invasive tissue ablation methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.